Novo Nordisk Aktie
42,10
EUR
+0,35
EUR
+0,83
%
42,20
EUR
+0,38
EUR
+0,90
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
| 02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.11.18 | Novo Nordisk buy | UBS AG | |
| 02.11.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 01.11.18 | Novo Nordisk buy | UBS AG | |
| 26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.10.18 | Novo Nordisk buy | UBS AG | |
| 10.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.10.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 05.10.18 | Novo Nordisk buy | UBS AG | |
| 04.10.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.08.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.18 | Novo Nordisk buy | UBS AG | |
| 08.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.07.18 | Novo Nordisk buy | UBS AG | |
| 23.07.18 | Novo Nordisk Outperform | Bernstein Research | |
| 11.07.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 11.07.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 02.07.18 | Novo Nordisk Outperform | Bernstein Research | |
| 28.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 25.06.18 | Novo Nordisk buy | UBS AG | |
| 21.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 21.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.18 | Novo Nordisk buy | UBS AG | |
| 08.06.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
| 30.05.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.05.18 | Novo Nordisk buy | UBS AG | |
| 03.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.05.18 | Novo Nordisk buy | UBS AG | |
| 02.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung